Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
- PMID: 38321120
- PMCID: PMC11189720
- DOI: 10.1038/s41380-024-02425-8
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Abstract
Smell deficits and neurobiological changes in the olfactory bulb (OB) and olfactory epithelium (OE) have been observed in schizophrenia and related disorders. The OE is the most peripheral olfactory system located outside the cranium, and is connected with the brain via direct neuronal projections to the OB. Nevertheless, it is unknown whether and how a disturbance of the OE affects the OB in schizophrenia and related disorders. Addressing this gap would be the first step in studying the impact of OE pathology in the disease pathophysiology in the brain. In this cross-species study, we observed that chronic, local OE inflammation with a set of upregulated genes in an inducible olfactory inflammation (IOI) mouse model led to a volume reduction, layer structure changes, and alterations of neuron functionality in the OB. Furthermore, IOI model also displayed behavioral deficits relevant to negative symptoms (avolition) in parallel to smell deficits. In first episode psychosis (FEP) patients, we observed a significant alteration in immune/inflammation-related molecular signatures in olfactory neuronal cells (ONCs) enriched from biopsied OE and a significant reduction in the OB volume, compared with those of healthy controls (HC). The increased expression of immune/inflammation-related molecules in ONCs was significantly correlated to the OB volume reduction in FEP patients, but no correlation was found in HCs. Moreover, the increased expression of human orthologues of the IOI genes in ONCs was significantly correlated with the OB volume reduction in FEP, but not in HCs. Together, our study implies a potential mechanism of the OE-OB pathology in patients with psychotic disorders (schizophrenia and related disorders). We hope that this mechanism may have a cross-disease implication, including COVID-19-elicited mental conditions that include smell deficits.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
COMPETING INTERESTS
The authors declare no competing interests.
Figures




Update of
-
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders.bioRxiv [Preprint]. 2024 Jan 10:2022.09.23.509224. doi: 10.1101/2022.09.23.509224. bioRxiv. 2024. Update in: Mol Psychiatry. 2024 May;29(5):1453-1464. doi: 10.1038/s41380-024-02425-8. PMID: 36203543 Free PMC article. Updated. Preprint.
Similar articles
-
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders.bioRxiv [Preprint]. 2024 Jan 10:2022.09.23.509224. doi: 10.1101/2022.09.23.509224. bioRxiv. 2024. Update in: Mol Psychiatry. 2024 May;29(5):1453-1464. doi: 10.1038/s41380-024-02425-8. PMID: 36203543 Free PMC article. Updated. Preprint.
-
The mechanisms underlying olfactory deficits in apolipoprotein E-deficient mice: focus on olfactory epithelium and olfactory bulb.Neurobiol Aging. 2018 Feb;62:20-33. doi: 10.1016/j.neurobiolaging.2017.09.036. Epub 2017 Oct 10. Neurobiol Aging. 2018. PMID: 29107844
-
Early deficits in olfaction are associated with structural and molecular alterations in the olfactory system of a Huntington disease mouse model.Hum Mol Genet. 2020 Aug 3;29(13):2134-2147. doi: 10.1093/hmg/ddaa099. Hum Mol Genet. 2020. PMID: 32436947
-
[Olfactory dysfunctions in patients with schizophrenia].Psychiatr Pol. 2007 Jul-Aug;41(4):503-12. Psychiatr Pol. 2007. PMID: 18046981 Review. Polish.
-
A comparative neuroimaging perspective of olfaction and higher-order olfactory processing: on health and disease.Semin Cell Dev Biol. 2022 Sep;129:22-30. doi: 10.1016/j.semcdb.2021.08.009. Epub 2021 Aug 27. Semin Cell Dev Biol. 2022. PMID: 34462249 Free PMC article. Review.
Cited by
-
Developmental Olfactory Dysfunction and Abnormal Odor Memory in Immune-Challenged Disc1+/- Mice.J Neurosci. 2025 Jun 18;45(25):e1007242025. doi: 10.1523/JNEUROSCI.1007-24.2025. J Neurosci. 2025. PMID: 40447445 Free PMC article.
-
Blood‑brain barrier dysfunction in schizophrenia: Mechanisms and implications (Review).Int J Mol Med. 2025 Oct;56(4):153. doi: 10.3892/ijmm.2025.5594. Epub 2025 Jul 25. Int J Mol Med. 2025. PMID: 40709398 Free PMC article. Review.
-
Beyond anosmia: olfactory dysfunction as a common denominator in neurodegenerative and neurodevelopmental disorders.Front Neurosci. 2024 Oct 30;18:1502779. doi: 10.3389/fnins.2024.1502779. eCollection 2024. Front Neurosci. 2024. PMID: 39539496 Free PMC article. Review.
-
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell.Allergy. 2025 Feb;80(2):440-461. doi: 10.1111/all.16338. Epub 2024 Oct 17. Allergy. 2025. PMID: 39418114 Free PMC article.
-
Aberrant aging-associated p62 autophagic cascade in biopsied olfactory neuronal cells from patients with psychosis.Schizophrenia (Heidelb). 2025 Apr 23;11(1):68. doi: 10.1038/s41537-025-00617-x. Schizophrenia (Heidelb). 2025. PMID: 40268926 Free PMC article.
References
-
- Cohen AS, Brown LA, Auster TL. Olfaction, ‘olfiction,’ and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophr Res. 2012;135:152–7. - PubMed
-
- Kopala LC, Good K, Honer WG. Olfactory identification ability in pre- and post-menopausal women with schizophrenia. Biol Psychiatry. 1995;38:57–63. - PubMed
MeSH terms
Grants and funding
- R21 MH128765/MH/NIMH NIH HHS/United States
- R01 AG064093/AG/NIA NIH HHS/United States
- R01 NS108452/NS/NINDS NIH HHS/United States
- R55 DC006213/DC/NIDCD NIH HHS/United States
- R01 MH105660/MH/NIMH NIH HHS/United States
- R01 AI132590/AI/NIAID NIH HHS/United States
- MH-107730/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R01 MH107730/MH/NIMH NIH HHS/United States
- DC-006213/U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD)
- R01 AG065168/AG/NIA NIH HHS/United States
- R01 DC020841/DC/NIDCD NIH HHS/United States
- R01 MH092443/MH/NIMH NIH HHS/United States
- MH-094268/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- NS-108452/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- DA-041208/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
- AG-064093/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- P50 MH094268/MH/NIMH NIH HHS/United States
- MH-105660/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- DC-016106/U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD)
- AG-065168/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- MH-092443/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- AI-132590/Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
- R01 DC016106/DC/NIDCD NIH HHS/United States
- MH-128765/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R01 DC006213/DC/NIDCD NIH HHS/United States
- R01 DA041208/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous